Far too many people across the world are living with undiagnosed diabetes.
Digostics enable healthcare providers to identify everyone with diabetes and those at risk of developing diabetes by eliminating the common barriers that inhibit accurate and timely testing using the gold-standard oral glucose tolerance test (OGTT).
Digostics is proud to offer GTT@home - the world’s first home OGTT offering and the most accessible and scalable way for clinical teams to realise their diabetes testing objectives.
Address
Harwell Innovation CentreertneC noitavonnI llewraH eunevA eirruC
Curie Avenue
Didcot
GQ0 11XO
United Kingdom
Contact Exhibitor
Products
-
The Future of Diabetes Detection, Today Introducing GTT@home, a revolutionary new diagnostic solution-as-a-service from Digostics that streamlines the diabetes screening workflow by taking effective a ...